These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28274636)

  • 21. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
    Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
    Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
    Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
    BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6 years and 2-35 months of age- an open-label, randomized phase IIb clinical trial.
    Hung MC; Cho CY; Chen CJ; Lai CC; Wu KG
    Vaccine; 2019 Sep; 37(37):5559-5566. PubMed ID: 31399275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Post-marketing multi-center safety surveillance of inactivated enterovirus A71 vaccine (Vero cell)].
    Zeng J; Tang T; Wang YJ; Lyu HK; Huang JH; Li XQ; Jia NN; Zeng G; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Mar; 53(3):252-257. PubMed ID: 30841662
    [No Abstract]   [Full Text] [Related]  

  • 27. Development of a sandwich ELISA to detect virus-like-particles in enterovirus A71 vaccines.
    Lim PY; Cardosa MJ
    J Virol Methods; 2019 Aug; 270():113-119. PubMed ID: 31100287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses against enterovirus A71 infection: Implications for vaccine success.
    Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
    Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.
    Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA
    Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
    Chang YK; Chen KH; Chen KT
    Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antivirals and vaccines for Enterovirus A71.
    Lin JY; Kung YA; Shih SR
    J Biomed Sci; 2019 Sep; 26(1):65. PubMed ID: 31481071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
    Zeng S; Meng X; Huang Q; Lei N; Zeng L; Jiang X; Guo X
    Int J Antimicrob Agents; 2019 Apr; 53(4):362-369. PubMed ID: 30599241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
    Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
    Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool.
    Tan CW; Tee HK; Lee MH; Sam IC; Chan YF
    PLoS One; 2016; 11(9):e0162771. PubMed ID: 27617744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan.
    Huang LM; Chiu CH; Chiu NC; Lin CY; Li MT; Kuo TY; Weng YJ; Hsieh EF; Tai IC
    Vaccine; 2019 Mar; 37(13):1827-1835. PubMed ID: 30803843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Immunogenicity of a Stable, Cold-Adapted, Temperature-Sensitive/Conditional Lethal Enterovirus A71 in Monkey Study.
    Chua KB; Ng Q; Meng T; Jia Q
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33803356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield.
    Chung CY; Chen CY; Lin SY; Chung YC; Chiu HY; Chi WK; Lin YL; Chiang BL; Chen WJ; Hu YC
    Vaccine; 2010 Oct; 28(43):6951-7. PubMed ID: 20797455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development.
    Yee PTI; Laa Poh C
    Virology; 2017 Jun; 506():121-129. PubMed ID: 28384566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation and purification of highly infectious enterovirus A71 particles using a strong anion-exchange column.
    Lien SC; Lu CC; Shen YS; Yang YT; Wu SR; Fang CY; Chow YH; Liao CL; Chiang JR; Liu CC
    J Chromatogr A; 2022 Sep; 1680():463427. PubMed ID: 36029731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis on post-marketing effectiveness and immunogenicity of enterovirus-A71 vaccine].
    Hua RJ; Huang J; Zhang XJ; Shen Q; Cai MY; Yuan F; Zhang Y; Cui PF; Li Y; Shi HY; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Sep; 41(9):1518-1521. PubMed ID: 33076610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.